| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/06/2007 | US7173027 Provide a physiological effect to a subject |
| 02/06/2007 | US7173024 Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use |
| 02/06/2007 | US7173020 Anticancer agents and drug delivery agents with nucleotides |
| 02/06/2007 | US7173008 Lyophilized HGF preparations |
| 02/06/2007 | US7172892 Exhibit protease activity as a single chain or as an activated two chain form; use of polypeptides to identify compounds that modulate the protease activity thereof and as tumor markers |
| 02/06/2007 | US7172876 Method of screening therapeutic agents for nerve degeneration associated diseases |
| 02/06/2007 | US7172871 Methods and compositions for modulating axonal outgrowth of central nervous system neurons |
| 02/06/2007 | US7172769 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 02/06/2007 | US7172767 Opioid agonist / antagonist combinations |
| 02/06/2007 | US7172753 Mixture of triazine, dibenzoylmethane and diarylbutadiene compound |
| 02/06/2007 | US7172752 Synergistic mixture of antiserotonine agents and glucocorticoids; inhalation |
| 02/06/2007 | US7172749 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| 02/06/2007 | CA2362816C Valdecoxib compositions |
| 02/06/2007 | CA2258662C Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 02/06/2007 | CA2132507C Method for altering hair growth and compositions used therefore |
| 02/03/2007 | CA2555119A1 New crystalline form iv of agomelatine, process for its preparation and pharmaceutical compositions containing it |
| 02/01/2007 | WO2007013696A1 Anti-tumor agent comprising 6'-amidino-2'-naphthyl4- guanidinobenzoate or salt thereof |
| 02/01/2007 | WO2007013694A1 Phenoxyalkanoic acid compound |
| 02/01/2007 | WO2007013691A1 Spiro-cyclic compound |
| 02/01/2007 | WO2007013689A1 Cyclopropanecarboxylic acid compound |
| 02/01/2007 | WO2007013677A1 Potentiator for substance having interferon-like effect |
| 02/01/2007 | WO2007013627A1 Therapeutic agent for b-lymphoma and hodgkin lymphoma |
| 02/01/2007 | WO2007013588A1 Strain of turkey tail mushroom, extract from the same, and use of the same |
| 02/01/2007 | WO2007013586A1 Novel peptide |
| 02/01/2007 | WO2007013522A1 Simon potato extract, glycosphingolipid derived from simon potato, and process for production of the extract or glycosphingolipid |
| 02/01/2007 | WO2007013501A1 Growth promoting agent and life prolonging agent |
| 02/01/2007 | WO2007013487A1 Method of producing bulk colistin powder |
| 02/01/2007 | WO2007013421A1 Novel nitrogenated heterocyclic compound |
| 02/01/2007 | WO2007013411A1 Anti-sense nucleic acid derived from organism |
| 02/01/2007 | WO2007013352A1 Medicinal composition containing hla-a24 molecule-binding peptide originating in parathyroid hormone-related protein |
| 02/01/2007 | WO2007013290A1 Anti-inflammatory analgesic agent |
| 02/01/2007 | US20070028315 DNA encoding SNORF33 receptor |
| 02/01/2007 | US20070027328 Processes for desolvating solvates of atorvastatin hemi-calcium and atorvastatin hem-calcium essentially free of organic solvent |
| 02/01/2007 | US20070027304 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070027215 Nuclear receptor ligands and ligand binding domains |
| 02/01/2007 | US20070027197 Pharmaceutical composition and method for the treatment of diseases using HMG-CoA reductase inhibitors and insulin secretion enhancers or sensitizers |
| 02/01/2007 | US20070027174 Phenylalanine Enamide Derivatives |
| 02/01/2007 | US20070027167 Use of c-Src inhibitors alone or in combinaton with STI571 for the treatment of leukaemia |
| 02/01/2007 | US20070027147 Biarylurea derivatives |
| 02/01/2007 | US20070027144 Novel use of cannabinoid receptor agonist |
| 02/01/2007 | US20070027138 Derivatives and analogs of galanthamine |
| 02/01/2007 | US20070027131 N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine; antiinflammatory, antiarthritic agents |
| 02/01/2007 | US20070027101 Treating ocular neovascular disease using anti-VEGF therapy in combination with a second therapy that inhibits the development of ocular neovascularization or destroys abnormal blood vessels in the eye, such as photodynamic therapy |
| 02/01/2007 | US20070027086 use for treatment of medical and veterinary conditions which can be influenced by the MC1-receptor; act as antiinflammatory and immunomodulatory agent; inhibit the production of nitric oxide (NO) |
| 02/01/2007 | US20070026494 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026470 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026422 Vaccine-induced hepatitis B viral strain and uses thereof |
| 02/01/2007 | US20070026091 Preparation and Administration of Jojoba Product for Reducing Weight, Fat and Blood Lipid Levels and for the Prevention and Treatment of Cancer |
| 02/01/2007 | US20070026070 Cross-linked polysaccharide composition |
| 02/01/2007 | US20070026066 Oral pharmaceutical delivery system with improved sustained release |
| 02/01/2007 | US20070026051 Use of tripolidine in providing refreshedness on waking |
| 02/01/2007 | US20070026036 Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease |
| 02/01/2007 | US20070026007 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 02/01/2007 | US20070026001 APO-2 ligand-anti-her-2 antibody synergism |
| 02/01/2007 | US20070025996 Oculospanin as a tumor specific antigen and methods and compositions utilizing same |
| 02/01/2007 | US20070025994 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 02/01/2007 | US20070025984 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms |
| 02/01/2007 | US20070025965 Therapies for renal failure using interferon-beta |
| 02/01/2007 | US20070025913 Immunoglobulin which specifically binds endothelial cell-specific polypeptides; for use as evaluative tool in immunodiagnostic and drug efficacy studies |
| 02/01/2007 | CA2617042A1 Spiro-cyclic compound |
| 02/01/2007 | CA2616534A1 Antitumor agent comprising 6'-amidino-2'-naphthyl4- guanidinobenzoate or salt thereof |
| 02/01/2007 | CA2616004A1 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
| 01/31/2007 | EP1748069A1 Follistatin mutant polypeptide |
| 01/31/2007 | EP1748048A1 Imidazopyridine compound |
| 01/31/2007 | EP1748046A2 Inhibitors of histone deacetylase |
| 01/31/2007 | EP1748044A1 Thiazole compound and use thereof |
| 01/31/2007 | EP1747778A1 Antifatigue composition |
| 01/31/2007 | EP1746999A1 4-phenylamino-quinazolin-6-yl-amides |
| 01/31/2007 | EP1509516B1 Inhibitors of the gpib -vwf interaction, their preparation and use |
| 01/31/2007 | EP1478357B1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 01/31/2007 | EP1320373B1 Treatment of arthritis and compositions therefore |
| 01/31/2007 | EP1194138B1 Nutritional supplements |
| 01/31/2007 | CN1906211A Novel muscle growth regulator |
| 01/31/2007 | CN1906203A Glycosaminoglycan (GAG) mimetics |
| 01/31/2007 | CN1906167A Novel pyridine derivative and pyrimidine derivative (2) |
| 01/31/2007 | CN1906166A Novel pyridine derivative and pyrimidine derivative (1) |
| 01/31/2007 | CN1906162A Hydroxy piperidine derivatives to treat gaucher disease |
| 01/31/2007 | CN1905866A Tulobuterol adhesive patch |
| 01/31/2007 | CN1903365A Drug-carried nanometer particles, and its preparing process for preparing medicien prepn. for anti-restenosis of blood-vessel |
| 01/31/2007 | CN1903313A Traditional Chinese medicine pills for dispelling stagancy and eliminating phlegm, and its prepn. method |
| 01/31/2007 | CN1903306A Traditional Chinese medicine bag for regulating balance of yin and yang, and its prepn. method |
| 01/31/2007 | CN1903259A Method for extraction and separation of moutan bark |
| 01/31/2007 | CN1903205A Agent for derivating metamorphosis of sea cyphonaute larva based on information transfer, and its application |
| 01/31/2007 | CN1297559C Fused bicyclic pyrimidine derivatives |
| 01/31/2007 | CN1297558C 4-oxo-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds, preparation method thereof and pharmaceutical composition containing them |
| 01/31/2007 | CN1297554C Amido ether substituted imidazoquinolines |
| 01/31/2007 | CN1297548C Cyclic hemiacetal derivative and use thereof |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/31/2007 | CN1297540C New derivatives of pyridilethanol (phenylethyl) amines as cholesterol biosynthesis inhibitors, procedures of their preparation and pharmaceutical preparations which they contain |
| 01/31/2007 | CN1297527C Stabilized compositions of aqueous reduced coenzyme Q solution |
| 01/31/2007 | CN1297302C Extract of cocoa tea in application for preparing medication of foodstuff of preventing and improving fatigue and clinical symptom |
| 01/31/2007 | CN1297270C Ophthalmic composition comprising ascomycin |
| 01/31/2007 | CN1297268C Melanogenesis inhibitors and whitening agents comprising egonol derivatives and compositions containing egonol derivatives |
| 01/31/2007 | CN1297266C Stabilized ascorbic acid derivatives |
| 01/31/2007 | CN1297265C Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases |
| 01/31/2007 | CN1297262C Compositions for lessening oxidative stress |
| 01/30/2007 | US7169951 Quinazoline derivatives and pharmaceutical applications thereof |
| 01/30/2007 | US7169929 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/30/2007 | US7169928 central nervous system disorders; Alzheimer's disease; attention deficit disorders; cognition activators; psychological disorders; antidepressants |
| 01/30/2007 | US7169927 Heterocyclic amides or prodrugs used in the treatment of diabetes, insulin resistance, metabolic disorders and obesity |